Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Molecular Templates logo — Engineering the Next Generation of Therapeutics

Molecular Templates

Engineering the Next Generation of Therapeutics

Founded 2001 United States Austin, United States 26 employees Post-IPO Equity Total: $372.65M Biotechnology, Health Care +1

General Information

Company Name Molecular Templates
Founded Year 2001
Location United States Austin, United States
Founders / Decision Makers
Team member
Employees 26
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Post-IPO Equity
Business Model B2B, Platform
Revenue Model Licensing, Performance Based
Social

BounceWatch is an independent company data service, not affiliated with Molecular Templates. To contact Molecular Templates, visit mtem.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Molecular Templates compare?

A PDF of Molecular Templates and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Molecular Templates soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Molecular Templates

Molecular Templates, headquartered in Austin, Texas, is a cutting-edge biopharmaceutical firm dedicated to innovating the realm of biologic therapeutics. Their focus lies in developing treatments for cancer and other severe illnesses using their proprietary biologic engineered toxin body (ETB) drug platform. This unique platform offers a novel mechanism of action distinctly different from traditional antibody drug conjugates (ADCs).

Currently, Molecular Templates has a robust pipeline of ETBs in development. Notable among these are MT-6402, MT-5111, and MT-0169, all in Phase I clinical trials targeting various types of cancer. The firm also collaborates with industry giant Bristol Myers Squibb to develop novel ETB-based therapies.

Established in 2001, Molecular Templates has continued to garner interest from investors, evidenced by the recent $9.50M Post-IPO equity investment from Santé Ventures, BB Biotech Ventures, and BVF Partners. The company's strategic partnerships and continuous innovations make it a compelling prospect for investment in the biotechnology sector.

Business keywords: biopharmaceutical, clinical-stage, cancer treatment, biologic therapeutics, engineered toxin body, ETB drug platform, antibody drug conjugates, PD-1/PD-L1, HER2-positive cancers, myeloma treatment, CTLA-4, TIGIT, TROP2, BCMA, collaboration agreement

Services & Products

clinical trials
drug discovery
biopharmaceutical research

Target Customers

pharmaceutical companies healthcare providers biotechnology investors

Funding Rounds & Investors (15)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $9.50M 3
Santé Ventures BB Biotech Ventures BVF Partners
Santé Ventures, BB Biotech Ventures +1
28 Mar 2024
Post IPO Equity $40.00M 3
Santé Ventures BB Biotech Ventures BVF Partners
Santé Ventures, BB Biotech Ventures +1
13 Jul 2023
Post IPO Equity $75.90M -
18 Feb 2021
Post IPO Debt $45.00M 2
Frazier Healthcare Partners K2 HealthVentures
Frazier Healthcare Partners, K2 HealthVentures
22 Mar 2020
Post IPO Equity $50.00M -
21 Nov 2019
Post IPO Equity $52.00M -
19 Sep 2018
Post IPO Equity $60.00M 5
Longitude Capital CAM Capital Perceptive Advisors
Longitude Capital, CAM Capital +3
16 Aug 2017
Series D $4.50M 1
Santé Ventures
Santé Ventures
29 Dec 2015
Series C $3.50M 2
Santé Ventures Aju IB Investment
Santé Ventures, Aju IB Investment
15 Sep 2014
Venture Round $7.00M 2
Santé Ventures Excel Venture Management
Santé Ventures, Excel Venture Management
03 Jul 2014

View All 15 Funding Rounds

Molecular Templates Alternatives & Competitors

View All Alternatives
Molecular Templates vs
Biotheryx, Inc.
Biotheryx, Inc. United States

Degrading proteins. Saving lives. Building the leader in next-generation targeted protein degradatio...

Series E
27 employees
Biotechnology, Health Care
Molecular Templates vs
Mersana Therapeutics
Mersana Therapeutics United States

Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for patients fi...

Acquired
159 employees
Biotechnology, Health Care
Molecular Templates vs
Heidelberg Pharma Research GmbH
Heidelberg Pharma Research GmbH Germany

For current information on Heidelberg Pharma Research GmbH, please refer to the Heidelberg Pharma AG...

Post-IPO Secondary
37 employees
Biotechnology, Health Care
Compare Molecular Templates vs Heidelberg Pharma Research GmbH
View all alternatives

FAQ About Molecular Templates

Engineering the Next Generation of Therapeutics
Molecular Templates was founded in 2001.
Molecular Templates is headquartered in Austin, United States.
Molecular Templates operates in Biotechnology, Health Care and Health and Wellness. Its work centres on biopharmaceutical, clinical-stage, cancer treatment and biologic therapeutics. Its customers include pharmaceutical companies, healthcare providers and biotechnology investors.
Molecular Templates has a B2B and Platform business model. Its revenue comes from Licensing and Performance Based.
Molecular Templates has approximately 26 employees.
Molecular Templates has completed 15 funding rounds, raising a total of $372.65M. The latest funding stage is Post-IPO Equity.
Molecular Templates offers: clinical trials, drug discovery, biopharmaceutical research.
Top alternatives and competitors to Molecular Templates include Biotheryx, Inc., Mersana Therapeutics, Heidelberg Pharma Research GmbH, Apexigen, Emergence Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Molecular Templates and Biotheryx, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Molecular Templates, https://bouncewatch.com/company/molecular-templates, updated 10 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout